Goro Miyakoda

571 total citations
22 papers, 482 citations indexed

About

Goro Miyakoda is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Goro Miyakoda has authored 22 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 7 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Goro Miyakoda's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Ion channel regulation and function (4 papers). Goro Miyakoda is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Ion channel regulation and function (4 papers). Goro Miyakoda collaborates with scholars based in Japan, Spain and Finland. Goro Miyakoda's co-authors include Toyoki Mori, Ayako Hashimoto, Hideki Ito, Takao Nakamura, Mari Fukunaga, Yutaka Matsumoto, Makoto Ishikawa, Youichi Yabuuchi, Hiroshi Yao and Haruhiko Takisawa and has published in prestigious journals such as PLoS ONE, Brain Research and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Goro Miyakoda

22 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Goro Miyakoda Japan	12	194	137	98	90	68	22	482
Yung Woo Shin South Korea	10	180 0.9×	107 0.8×	92 0.9×	74 0.8×	30 0.4×	51	456
Elena Nobili Italy	13	121 0.6×	189 1.4×	130 1.3×	71 0.8×	38 0.6×	16	562
Alice Pignieri Italy	11	150 0.8×	138 1.0×	67 0.7×	71 0.8×	21 0.3×	14	463
Laura Agnoletti Italy	9	261 1.3×	216 1.6×	57 0.6×	161 1.8×	135 2.0×	17	700
Ayumi Ide Japan	11	417 2.1×	247 1.8×	90 0.9×	90 1.0×	29 0.4×	11	719
M. J. Panzenbeck United States	16	170 0.9×	135 1.0×	31 0.3×	107 1.2×	36 0.5×	28	548
Yoichi Miwa Japan	12	242 1.2×	125 0.9×	158 1.6×	161 1.8×	33 0.5×	18	545
Hangjun Zhang Canada	11	197 1.0×	221 1.6×	84 0.9×	71 0.8×	27 0.4×	20	524
Haruhisa Sato Japan	9	79 0.4×	205 1.5×	67 0.7×	105 1.2×	25 0.4×	11	634
M. S. Klevesath Germany	5	60 0.3×	149 1.1×	42 0.4×	111 1.2×	71 1.0×	6	569

Countries citing papers authored by Goro Miyakoda

Since Specialization

Citations

This map shows the geographic impact of Goro Miyakoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goro Miyakoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goro Miyakoda more than expected).

Fields of papers citing papers by Goro Miyakoda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Goro Miyakoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goro Miyakoda. The network helps show where Goro Miyakoda may publish in the future.

Co-authorship network of co-authors of Goro Miyakoda

This figure shows the co-authorship network connecting the top 25 collaborators of Goro Miyakoda. A scholar is included among the top collaborators of Goro Miyakoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Goro Miyakoda. Goro Miyakoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ogino, Atsushi, Genzou Takemura, Ayako Hashimoto, et al.. (2015). OPC-28326, a selective peripheral vasodilator with angiogenic activity, mitigates postinfarction cardiac remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 309(1). H213–H221. 1 indexed citations

Ito, Hideki, Kenji Uehara, Yutaka Matsumoto, et al.. (2012). Cilostazol Inhibits Accumulation of Triglyceride in Aorta and Platelet Aggregation in Cholesterol-Fed Rabbits. PLoS ONE. 7(6). e39374–e39374. 15 indexed citations

Ito, Hideki, Ayako Hashimoto, Yutaka Matsumoto, Hiroshi Yao, & Goro Miyakoda. (2009). Cilostazol, a Phosphodiesterase Inhibitor, Attenuates Photothrombotic Focal Ischemic Brain Injury in Hypertensive Rats. Journal of Cerebral Blood Flow & Metabolism. 30(2). 343–351. 34 indexed citations

Yoshikawa, Tomohiro, et al.. (2008). Cilostazol inhibits modified low-density lipoprotein uptake and foam cell formation in mouse peritoneal macrophages. Atherosclerosis. 204(2). 405–411. 22 indexed citations

Yoshikawa, T., et al.. (2008). Antiatherogenic Effects of Cilostazol and Probucol Alone, and in Combination in Low Density Lipoprotein Receptor-deficient Mice Fed with a High Fat Diet. Hormone and Metabolic Research. 40(7). 473–478. 18 indexed citations

Ito, Hideki, Mari Fukunaga, Hidenori Suzuki, et al.. (2008). Effect of cilostazol on delayed cerebral vasospasm after subarachnoid hemorrhage in rats: Evaluation using black blood magnetic resonance imaging. Neurobiology of Disease. 32(1). 157–161. 24 indexed citations

Yoshikawa, T., et al.. (2008). ANTIATHEROGENIC EFFECTS OF CILOSTAZOL AND PROBUCOL ALONE, AND IN COMBINATION IN LOW DENSITY LIPOPROTEIN RECEPTOR-DEFICIENT MICE FED A HIGH-FAT DIET. Atherosclerosis Supplements. 9(1). 29–29. 1 indexed citations

Suzuki, Shinya, et al.. (2007). Induction of Metallothionein Synthesis by Cilostazol in Mice and in Human Cultured Neuronal Cell Lines. Biological and Pharmaceutical Bulletin. 30(4). 791–794. 11 indexed citations

Hashimoto, Ayako, et al.. (2006). Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis. 189(2). 350–357. 175 indexed citations

10.

Ito, Hideki, Goro Miyakoda, & Toyoki Mori. (2004). Cilostazol inhibits platelet–leukocyte interaction by suppression of platelet activation. Platelets. 15(5). 293–301. 26 indexed citations

11.

Hirose, Yoshinobu, et al.. (2003). 1P-0260 Cilostazol, a selective phosphodiesterase 3 (PDE3) inhibitor, possesses protective effect on endothelium. Atherosclerosis Supplements. 4(2). 76–76. 1 indexed citations

12.

Lee, Jeong Hyun, Yong-Kyu Lee, Makoto Ishikawa, et al.. (2003). Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats—an MRI study. Brain Research. 994(1). 91–98. 47 indexed citations

13.

Mori, Toyoki, Tadayoshi Takeuchi, M. Ohura, et al.. (1998). Pranidipine, a new 1, 4-dihydropyridine calcium channel blocker, enhances cyclic GMP-independent nitric oxide-induced relaxation of the rat aorta. Molecular and Cellular Biochemistry. 178(1-2). 335–343. 16 indexed citations

14.

Ohura, M., Kensuke Orito, Goro Miyakoda, & Toyoki Mori. (1997). The selective vascular and negative chronotropic effects versus negative inotropic effects of pranidipine, a new 1,4-dihydropyridine calcium channel blocker, in isolated rat preparations.. The Japanese Journal of Pharmacology. 73. 70–70. 1 indexed citations

15.

Hirano, Takahiro, M. Ohura, Kensuke Orito, et al.. (1997). Venodilator effects of pranidipine, a 1,4-dihydropyridine Ca2+ channel antagonist, in rats: comparison with nifedipine and amlodipine. European Journal of Pharmacology. 324(2-3). 201–204. 11 indexed citations

16.

Miyakoda, Goro, Natsuki Nakayama, Kazuki Matsui, & Atsushi Yabuuchi. (1995). Mechanisms of the potent and long-lasting antihypertensive action of the new calcium channel blocker pranidipine. Evidence for strong affinity to the calcium channels or membranes.. PubMed. 45(4). 471–5. 7 indexed citations

17.

Nakayama, Natsuki, et al.. (1991). Hypotensive Effect and Cerebral Blood Flow Increasing Action of OPC-13340, a New Long Acting Ca antagonist, in Aged SHR. Japanese Heart Journal. 32(4). 561–561. 4 indexed citations

18.

Miyakoda, Goro, Akira Yoshida, Haruhiko Takisawa, & Takao Nakamura. (1987). β-Adrenergic Regulation of Contractility and Protein Phosphorylation in Spontaneously Beating Isolated Rat Myocardial Cells1. The Journal of Biochemistry. 102(1). 211–224. 22 indexed citations

19.

Kobayashi, Masaki, Goro Miyakoda, Takao Nakamura, & Yasushi Ohizumi. (1985). Ca-dependent arrhythmogenic effects of maitotoxin, the most potent marine toxin known, on isolated rat cardiac muscle cells. European Journal of Pharmacology. 111(1). 121–123. 18 indexed citations

20.

Miyakoda, Goro & Takao Nakamura. (1982). Reversible Effects of a High-Molecular Weight Sulfhydryl Reagent on the Contractile Activity of Myocardial Cells Isolated from Adult Rat Heart1. The Journal of Biochemistry. 92(6). 1833–1843. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact